alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin]
- RxCUI
- 1661220
- RxNorm name
- alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin]
- Display name
- alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin]
- Full name
- alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103174 | prolastin,prolastin-c,prolastin-c liquid | Alpha-1-Proteinase Inhibitor (Human) | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 91edab72-c889-470e-8315-1798b5548dca | Prolastin-C 1 MG Injection [PSN] · alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin] [SBD] · Prolastin 1 MG Injection [SY] | 3 | 25 | These highlights do not include all the information needed to use PROLASTIN ® -C safely and effectively. See full prescribing information for PROLASTIN-C. PROLASTIN ® -C (Alpha 1 -Proteinase Inhibitor [Human]) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 1987 | 20220225 |
| 2b620e6b-6a24-0957-1288-ae529c4cc3a2 | Prolastin-C 1 MG Injection [PSN] · alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin] [SBD] · Prolastin 1 MG Injection [SY] | 3 | 14 | These highlights do not include all the information needed to use PROLASTIN-C LIQUID safely and effectively. See full prescribing information for PROLASTIN-C LIQUID. PROLASTIN-C LIQUID (Alpha 1 -Proteinase Inhibitor [Human]) Solution for Intravenous Injection Initial U.S. Approval: 1987 | 20220705 |